Skip to main content
Top

Evaluation of an Integrated Intensive Cognitive Behavioral Therapy Treatment Within Addiction Care

Published in:

Abstract

The study aimed to evaluate an integrated intensive cognitive behavioral therapy (CBT) group treatment for people with substance-related syndrome in outpatient care and to identify eventual gender differences. The study population consisted of 35 outpatients (18 male, 17 female) at a clinic in Western Sweden. The patients completed a four-month period of intensive group therapy and participated in the data collection at admission and discharge. The data were collected using the following inventories: Beck Depression and Anxiety Inventories, Rosenberg Self-Esteem Scale, Hopelessness Scale, and Trait Hope Scale. Results showed decreases in anxiety, depression and experience of hopelessness, and increases in self-esteem and hope. In females, the most dramatic improvement was measured for the anxiety and depression attributes, while in males the strongest effect was measured for hope and self-esteem. This study provides clinical evidence of the positive effects of integrated intensive CBT in outpatient care of people with substance-related syndrome.
Title
Evaluation of an Integrated Intensive Cognitive Behavioral Therapy Treatment Within Addiction Care
Authors
Kourosh Bador, MSc
Nóra Kerekes, PhD
Publication date
01-01-2020
Publisher
Springer US
Published in
The Journal of Behavioral Health Services & Research / Issue 1/2020
Print ISSN: 1094-3412
Electronic ISSN: 1556-3308
DOI
https://doi.org/10.1007/s11414-019-09657-5
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video

Keynote webinar | Spotlight on addressing alcohol-associated liver disease

The global burden of ALD is growing and compounded by frequent late-stage diagnosis and undertreatment. Get the latest insights and advances in alcohol-associated liver disease, from patient risk and identification to treatment and management, plus the arrival of MetALD and what it means for patient care.

Prof. Helena Cortez-Pinto
Prof. Mark Thursz
Dr. Juan Pablo Arab
Learn more
Video
Image Credits
Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images, Abstract low poly wireframe illustration of the liver/© (M) Yevhen Lahunov / iStock / Getty Images Plus